Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 3 · 100%High 0 · 0%

PPI triple therapy for 14 days vs 7 days

H. pylori persistence, regardless of regimen and dose · patients with Helicobacter pylori infection

PPI triple therapy for 14 days probably leads to lower H. pylori persistence, regardless of regimen and dose compared with 7 days (moderate certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 0.66 [0.6, 0.74]
45 studies · 7722 participants
Moderate

PPI triple therapy for 14 days vs 10 days

H. pylori persistence, regardless of regimen and dose · patients with Helicobacter pylori infection

PPI triple therapy for 14 days probably leads to lower H.pylori persistence, regardless of regimen and dose compared with 10 days (moderate certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 0.72 [0.58, 0.9]
12 studies · 2111 participants
Moderate

PPI triple therapy for 10 days vs 7 days

H. pylori persistence, regardless of regimen and dose · patients with Helicobacter pylori infection

PPI triple therapy for 10 days probably leads to lower H. pylori persistence, regardless of regimen and dose compared with 7 days (moderate certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 0.8 [0.72, 0.89]
24 studies · 4628 participants
Moderate